The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The added value of ordinal analysis in clinical trials: an example in traumatic brain injury
Open accessAbstract
Introduction: In clinical trials, ordinal outcome measures are often dichotomized into two categories. In traumatic brain injury (TBI) the 5-point Glasgow outcome scale (GOS) is collapsed into unfavourable versus favourable outcome. Simulation studies have shown that exploiting the ordinal nature of the GOS increases chances of detecting treatment effects. The objective of this study is to quantify the benefits of ordinal analysis in the real-life situation of a large TBI trial. Methods: We used data from the CRASH trial that investigated the efficacy of corticosteroids in TBI patients (n = 9,554). We applied two techniques for ordinal analysis: proportional odds analysis and the sliding dichotomy approach, where the GOS is dichotomized at different cut-offs according to baseline prognostic risk. These approaches were compared to dichotomous analysis. The information density in each analysis was indicated by a Wald statistic. All analyses were adjusted for baseline characteristics. Results: Dichotomous analysis of the six-month GOS showed a non-significant treatment effect (OR = 1.09, 95% CI 0.98 to 1.21, P = 0.096). Ordinal analysis with proportional odds regression or sliding dichotomy showed highly statistically significant treatment effects (OR 1.15, 95% CI 1.06 to 1.25, P = 0.0007 and 1.19, 95% CI 1.08 to 1.30, P = 0.0002), with 2.05-fold and 2.56-fold higher information density compared to the dichotomous approach respectively. Conclusions: Analysis of the CRASH trial data confirmed that ordinal analysis of outcome substantially increases statistical power. We expect these results to hold for other fields of critical care medicine that use ordinal outcome measures and recommend that future trials adopt ordinal analyses. This will permit detection of smaller treatment effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical trials in head injury
Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., et al. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754037 · Cited by 913 · cited 1×
“Heterogeneity of the population and limitations of the conventional statistical analysis of TBI trials contribute to this lack of success [2,3].”
BackgroundSelf-citationNXY-059 for Acute Ischemic Stroke
Lees, K. R., Zivin, J. A., Ashwood, T., Davalos, A., Davis, S. M., Diener, H.-C., Grotta, J., Lyden, P., Shuaib, A., Hårdemark, H.-G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052980 · Cited by 660
Clinical trials in traumatic brain injury: past experience and current developments
Maas, A. I. R., Roozenbeek, B., & Manley, G. T. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2009.10.022 · Cited by 291 · cited 1×
“Since the 1980s, at least 33 randomized controlled phase III trials have been performed to investigate the effectiveness of new therapeutic interventions in TBI, but none has convincingly demonstrated benefit in the overall population [1].”
BackgroundSelf-citationThe Optimising Analysis of Stroke Trials (OAST) Collaboration (2007) · Stroke · doi:10.1161/strokeaha.106.474080 · Cited by 192
Maas, A. I. R., Steyerberg, E. W., Marmarou, A., McHugh, G. S., Lingsma, H. F., Butcher, I., Lu, J., Weir, J., Roozenbeek, B., & Murray, G. D. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2009.10.020 · Cited by 157
Self-citationMeasurement in clinical trials: A neglected issue for statisticians?
Senn, S., & Julious, S. (2009) · Statistics in Medicine · doi:10.1002/sim.3603 · Cited by 136 · cited 2×
“We can, however, interpret the common odds ratio as a summary measure of treatment effect, even if the odds ratios differ by cut-off [8].”
BackgroundMcHugh, G. S., Butcher, I., Steyerberg, E. W., Marmarou, A., Lu, J., Lingsma, H. F., Weir, J., Maas, A. I. R., & Murray, G. D. (2010) · Clinical Trials · doi:10.1177/1740774509356580 · Cited by 108
Self-citation
Cited by
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research
Maas, A. I. R., Menon, D. K., Adelson, P. D., Andelic, N., Bell, M. J., Belli, A., Bragge, P., Brazinova, A., Büki, A., Chesnut, R. M., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30371-x · Cited by 2,609
Self-citationTrial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
Hutchinson, P. J., Kolias, A. G., Timofeev, I. S., Corteen, E. A., Czosnyka, M., Timothy, J., Anderson, I., Bulters, D. O., Belli, A., Eynon, C. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1605215 · Cited by 1,289
Self-citationHypothermia for Intracranial Hypertension after Traumatic Brain Injury
Andrews, P. J. D., Sinclair, H. L., Rodriguez, A., Harris, B. A., Battison, C. G., Rhodes, J. K. J., & Murray, G. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507581 · Cited by 578
Self-citationMagnetic resonance imaging improves 3‐month outcome prediction in mild traumatic brain injury
Yuh, E. L., Mukherjee, P., Lingsma, H. F., Yue, J. K., Ferguson, A. R., Gordon, W. A., Valadka, A. B., Schnyer, D. M., Okonkwo, D. O., Maas, A. I. R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23783 · Cited by 413
Self-citationThe Glasgow Outcome Scale — 40 years of application and refinement
McMillan, T., Wilson, L., Ponsford, J., Levin, H., Teasdale, G., & Bond, M. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.89 · Cited by 410
Metadata
- Authors
- Roozenbeek, B., Lingsma, H. F., Perel, P., Edwards, P., Roberts, I., Murray, G. D., Maas, A. I., Steyerberg, E. W., & the IMPACT (International Mission on Prognosis and Clinical Trial Design in Traumatic Brain Injury) Study Group and the CRASH (Corticosteroid Randomisation After Significant Head Injury) Trial Collaborators
- Venue
- Critical Care
- Published
- 2011-05-17
- Volume
- 15
- Issue
- 3
- Pages
- R127-R127
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2161864397
- Cited by
- 190
- References
- 7
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.